At a glance
ClinicalIndex Comparison RecordN/ACompleted· 55 enrolled
Drug / intervention
EPIONE® CT-Guided Percutaneous proceduresdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-Market Clinical Follow-Up Study of a Robotic Device for Image Guided Percutaneous Needle Placement in the Abdomen
In Brief
An observational study evaluating EPIONE® CT-Guided Percutaneous procedures for Cancer Abdomen. Completed, enrolled 55 participants across 1 site.
Detailed Summary
Post-Market Clinical Follow-up study in order to consolidate performance and safety data of the EPIONE® device when used for percutaneous procedures in the abdomen
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer Abdomen
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartApr 2022
First PostedSep 2022
Primary CompletionFeb 2023
Study CompletionApr 2024
TodayJul 2026
First PostedSep 7, 2022
Enrollment StartApr 28, 2022
Primary CompletionFeb 22, 2023
Study CompletionApr 27, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.8 years ago
Interventions
EPIONE® CT-Guided Percutaneous proceduresdevice
The EPIONE device is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures.